ReviewHeart (British Cardiac Society)2022
Supraventricular arrhythmia in pregnancy.
Review in Heart (British Cardiac Society), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 31 citations in OpenAlex.
- Article
- Cardiovascular Health in Women-Across the Lifespan.Clinical endocrinology · 2026Review
- Depression as a Cardiovascular Risk Marker in Pregnancy: Hypertensive and Arrhythmic Maternal Outcomes in a Retrospective Matched Cohort.Journal of clinical medicine · 2026Article
- Management of Arrhythmias During Pregnancy in Africa.Saudi medical journal · 2026Review
- Maternal Cardiovascular Emergencies During Pregnancy and the Puerperium: Current Diagnostic Approach and Management.Medicina (Kaunas, Lithuania) · 2026Review
- Pregnancy-Related Heart Disease in the Emergency Department.Journal of personalized medicine · 2025Review
- Article
- Navigating pregnancy with cardiovascular disease: pathophysiology, risk stratification, and maternal-fetal outcomes.Turkish journal of medical sciences · 2025Review
- Hotspots and Frontiers in Arrhythmias During Pregnancy: A Bibliometric Analysis.Journal of multidisciplinary healthcare · 2025Article
- Nonfluoroscopic catheter ablation of supraventricular tachycardias during pregnancy using simplified electroanatomic marker annotation.HeartRhythm case reports · 2024Article
- Successful Direct Current Cardioversion (DCCV) in Pregnancy in a Non-Obstetric Emergency Department.Cureus · 2024Article
- Exploring the Life Experiences of Living with Cardiac Arrhythmia Developed During Pregnancy.Healthcare (Basel, Switzerland) · 2024Article
- Pregnancy outcomes in patients complicated with pre-excitation syndrome.Archives of gynecology and obstetrics · 2024Article
- Zero-Fluoroscopy Catheter Ablation of Right Appendage Focal Atrial Tachycardia in a Pregnant Woman.Clinics and practice · 2024Article
- Electrocardiogram Features in Non-Cardiac Diseases: From Mechanisms to Practical Aspects.Journal of multidisciplinary healthcare · 2024Review
- Pregnancy Considerations in Tetralogy of Fallot.CJC pediatric and congenital heart disease · 2023Review
- The Challenge of Managing Atrial Fibrillation during Pregnancy.Reviews in cardiovascular medicine · 2023Review
- Sex and racial disparities in catheter ablation.Heart rhythm O2 · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The physiological changes during pregnancy predispose a woman for the development of new-onset or recurrent arrhythmia. Supraventricular arrhythmia is the most common form of arrhythmia during pregnancy and, although often benign in nature, can be concerning. We describe three complex cases of supraventricular arrhythmia during pregnancy and review the currently available literature on the subject. In pregnancies complicated by arrhythmia, a plan for follow-up and both maternal and fetal monitoring during pregnancy, delivery and post partum should be made in a multidisciplinary team. Diagnostic modalities should be used as in non-pregnant women if there is an indication. All antiarrhythmic drugs cross the placenta, but when necessary, medical treatment should be used with consideration to the fetus and the mother's altered pharmacodynamics and kinetics. Electrical cardioversion is safe during pregnancy, and electrophysiological study and catheter ablation can be performed in selected patients, preferably with zero-fluoroscopy technique. Sometimes, delivering the fetus (if viable) is the best therapeutic option. In this review, we provide a framework for the workup and clinical management of supraventricular arrhythmias in pregnant women, including cardiac, obstetric and neonatal perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.